Sign In
Buy ALT
$2.87
-0.0300 (-1.03%)
At Close: Jun 03, 2026
Altimmune, Inc. (ALT) CEO Vipin Garg on Q3 2020 Results - Earnings Call Transcript
01:20pm, Tuesday, 10'th Nov 2020
Altimmune, Inc. (ALT) CEO Vipin Garg on Q3 2020 Results - Earnings Call Transcript
Altimmune Takes Next Step With Its COVID-19 Intranasal Vaccine
12:18pm, Tuesday, 10'th Nov 2020
Altimmune Inc. (NASDAQ: ALT) stepped forward on Tuesday with its vaccine candidate for COVID-19.
Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal Vaccine Candidate for COVID-19
01:00am, Tuesday, 10'th Nov 2020
AdCOVID , a Single-dose Intranasal Vaccine for COVID-19 is Designed to Generate a Broad Immune Response Against COVID-19 with the Unique Ability to Promote Nasal Mucosal Immunity
Altimmune Announces Third Quarter 2020 Financial Results and Provides a Business Update
04:05pm, Monday, 09'th Nov 2020
GAITHERSBURG, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced financial results for the three and nine months ended Se
Altimmune to Announce Third Quarter 2020 Financial Results on November 10
08:00am, Tuesday, 03'rd Nov 2020
GAITHERSBURG, Md., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will release its third quarter 2020 financial re
Arena Wins Special Situations Manager of the Year at Alt Credit Fund Intelligence US Performance Awards 2020
12:00am, Thursday, 22'nd Oct 2020
Arena wins
Singles' Day Set To Propel Alibaba Higher (NYSE:BABA)
03:57pm, Monday, 19'th Oct 2020
Mainland and Hong Kong markets started the week bullish with the anticipation of positive policy developments from the Chinese president's tour of southern China.
Mid-Day Market Update: Gold Down 2%; Medigus Shares Spike Higher
12:00am, Tuesday, 13'th Oct 2020
Midway through trading Tuesday, the Dow traded down 0.25% to 28,766.88 while the NASDAQ rose 0.19% to 11,899.41. The S&P also fell, falling 0.28% to 3,524.36.
The U.S. has...
Seeking Yield With Safety
12:16pm, Monday, 12'th Oct 2020
Lipper categories with low risk and moderate to high yields are listed. Top-ranked funds within the categories are listed.
The Daily Biotech Pulse: Novavax Advances Vaccine, Marinus Gets Nod For Late-Stage Study, 3 IPOs
12:00am, Friday, 25'th Sep 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 24)
Beigene Ltd (NASDAQ: BGNE...
India OTT Video Services Market, Competition, Forecast & Opportunities, 2026 - ResearchAndMarkets.com
12:00am, Thursday, 24'th Sep 2020
The
Altimmune: The Late Bloomer Of The COVID-19 Biotech World, The Best Is Yet To Come (NASDAQ:ALT)
04:15am, Thursday, 17'th Sep 2020
I am bullish on Altimmune because of their two COVID-19 programs, T-COVID and AdCOVID. Specifically, T-COVID is reminiscent of a Tamiflu, but for COVID-19.
David Axelrod, Karl Rove and Matt VanDyke to Speak at TVB Alt Forward 2020 Conference
12:00am, Wednesday, 16'th Sep 2020
TVB’s 2020 Alt Forward Conference will be unlike any before - this year’s conference will be a fully virtual, multi-dimensional experience, taking pla
Coronavirus Vaccine Roundup, Early September
07:39am, Friday, 04'th Sep 2020
Taking a looking at the COVID-19 vaccine development landscape across various classes, including viral vectors, genetic vaccines, recombinant protein vaccines, attenuated virus vaccines, inactivated v
9 Reasons Why The Race For Major COVID-19 Vaccine Revenues Has Greatly Narrowed
10:06am, Wednesday, 02'nd Sep 2020
The huge amount of Operation Warp Speed funding for its six vaccines has helped them become somewhat dominant leaders in the race for a sizable share of the market.
